Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
Regional Management Corp
F:46F
|
US |
|
Vireo Growth Inc
OTC:VREOF
|
US |
|
Extendicare Inc
F:5XE
|
CA |
|
P
|
Pacific Biosciences of California Inc
F:P09
|
US |
|
Tenaris SA
NYSE:TS
|
LU |
|
S
|
Sumitomo Pharma Co Ltd
DUS:DPM
|
JP |
|
Babcock International Group PLC
LSE:BAB
|
UK |
|
B
|
Brown & Brown Inc
XBER:BTW
|
US |
|
B
|
Bank of Nova Scotia
XMUN:BKN
|
CA |
|
Fomento de Construcciones y Contratas SA
F:FCC
|
ES |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
Wall St Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for BM8 is 82.41 EUR with a low forecast of 52.64 EUR and a high forecast of 115.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BM8's stock price target?
Price Target
82.41
EUR
According to Wall Street analysts, the average 1-year price target for BM8 is 82.41 EUR with a low forecast of 52.64 EUR and a high forecast of 115.01 EUR.
What is the Revenue forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
48%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.
What is the Net Income forecast for Biomarin Pharmaceutical Inc?
Projected CAGR
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.
